ArticleJFMS open reports
Nasopharyngeal eosinophilic sclerosing fibroplasia in a 15-year-old cat: expanding the anatomical and age spectrum of the disease.
Article in JFMS open reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Case summary: A 15-year-old, spayed female domestic shorthair cat was evaluated for chronic progressive stertor, mucopurulent nasal discharge and intermittent apnoeic episodes. CT revealed a soft tissue mass occupying the nasopharynx and partially obstructing the choanae. Nasopharyngoscopy confirmed a firm, pale, multilobulated lesion. Partial endoscopic debulking of the mass was performed, although further sampling was limited by post-procedural haemorrhage. Histopathology demonstrated dense eosinophilic inflammation with marked sclerosing fibroplasia, consistent with feline eosinophilic sclerosing fibroplasia (FESF); no histological features suggestive of lymphoma, carcinoma, fungal disease or inflammatory polyps were identified. Prednisolone was initially administered to minimise the risk of post-procedural inflammatory nasopharyngeal stenosis and subsequently continued for 31 days after histological confirmation of FESF. Two months later, CT and nasopharyngoscopy demonstrated complete anatomical resolution with full remission of clinical signs. Relevance and novel information: Nasopharyngeal involvement of FESF has not previously been reported; the condition is typically described in young to middle-aged cats with gastrointestinal disease. More recent reports describe its possible lymph node localisation in sites beyond the abdominal cavity. This case documents a geriatric-onset, extra-gastrointestinal presentation mimicking neoplasia or granulomatous disease. Diagnosis was achieved on biopsies obtained during partial debulking, and follow-up investigations confirmed complete anatomical resolution. This case expands the recognised anatomical and age spectrum of FESF and supports consideration of this entity in the differential diagnoses for nasopharyngeal masses in cats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.